首页> 外文期刊>BMC Complementary and Alternative Medicine >Study of phytochemical, anti-microbial, anti-oxidant, and anti-cancer properties of Allium wallichii
【24h】

Study of phytochemical, anti-microbial, anti-oxidant, and anti-cancer properties of Allium wallichii

机译:葱属植物的化学,抗微生物,抗氧化和抗癌特性的研究

获取原文
       

摘要

Background There is growing interest in the use of plants for the treatment and prevention of cancer. Medicinal plants are currently being evaluated as source of promising anticancer agents. In this paper, we have investigated the anticancer potential of plant Allium wallichii , a plant native to Nepal and growing at elevations of 2300–4800 m. This is the first study of its kind for the plant mentioned. Methods The dried plant was extracted in aqueous ethanol. Phytochemical screening, anti-microbial assay, anti-oxidant assay, cytotoxicity assay and the flow-cytometric analysis were done for analyzing different phytochemicals present, anti-microbial activity, anti-oxidant activity and anti-cancer properties of Allium wallichii . Results We observed the presence of steroids, terpenoids, flavonoids, reducing sugars and glycosides in the plant extract and the plant showed moderate anti-microbial and anti-oxidant activity. The IC50 values of Allium wallichii in different cancer cell lines are 69.69?μg/ml for Prostate cancer (PC3) cell line, 55.29?μg/ml for Breast Cancer (MCF-7) cell line and 46.51?μg/ml for cervical cancer (HeLa) cell line as compared to Doxorubicin (0.85?μg/ml). The cell viability assay using FACS showed that the IC50value of Allium wallichii for Burkitt’s lymphoma (B-Lymphoma) cell line was 3.817?±?1.99?mg/ml. Conclusions Allium wallichii can be an important candidate to be used as an anticancer agent. Separation of pure compounds with bioassay guided extraction, spectrometric analysis and subsequent cytotoxicity assay of the pure bioactive compounds from Allium wallichii is highly recommended as the crude extract itself showed promising cytotoxicity.
机译:背景技术对于将植物用于治疗和预防癌症的兴趣日益增长。目前正在评估药用植物作为有前途的抗癌药的来源。在本文中,我们研究了尼泊尔原生的一种植物,生长在海拔2300-4800 m的植物葱属植物的抗癌潜力。这是针对所提及植物进行的首次此类研究。方法将干燥后的植物用乙醇水溶液萃取。进行了植物化学筛选,抗微生物测定,抗氧化剂测定,细胞毒性测定和流式细胞分析,以分析葱属植物存在的不同植物化学成分,抗微生物活性,抗氧化活性和抗癌特性。结果我们观察到植物提取物中存在类固醇,类萜,类黄酮,还原糖和糖苷,并且该植物显示出中等的抗微生物和抗氧化活性。不同癌细胞系中葱属的IC 50 值对于前列腺癌(PC3)细胞系为69.69?μg/ ml,对于乳腺癌(MCF-7)细胞系为55.29?μg/ ml。子宫颈癌(HeLa)细胞系的46.51微克/毫升,而阿霉素(0.85微克/毫升)。用FACS进行的细胞活力测定显示,葱属对伯基特氏淋巴瘤(B-淋巴瘤)细胞系的IC 50 值为3.817?±?1.99?mg / ml。结论葱属可以作为抗癌药的重要候选药物。强烈建议使用生物测定指导的提取,光谱分析和随后的细胞毒性测定法对来自葱属葱属植物的纯生物活性化合物进行分离,因为粗提取物本身显示出有希望的细胞毒性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号